Health Economics›Breast cancer›Adjuvant therapy sequential regimens

Adjuvant therapy sequential regimens

Breast cancer · 81 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

FiltersBiomarker

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
FEC-THP (Docetaxel) Variant #01	ERBB2	R 81 728	21d	—	—	—	—	1
ddEC-THP (Docetaxel) Variant #01	ERBB2	R 81 417	21d	—	—	—	—	1
EC-THP (Docetaxel) Variant #01	ERBB2	R 81 417	21d	—	—	—	—	1
ddAC-THP (Docetaxel) Variant #01	ERBB2	R 80 034	21d	—	—	—	—	1
AC-THP (Docetaxel) Variant #01	ERBB2	R 80 034	21d	—	—	—	—	1
FAC-THP (Docetaxel) Variant #01	ERBB2	R 80 007	21d	—	—	—	—	1
FEC-THP (Paclitaxel) Variant #01	ERBB2	R 78 322	21d	—	—	—	—	1
ddEC-THP (Paclitaxel) Variant #01	ERBB2	R 78 254	21d	—	—	—	—	1
EC-THP (Paclitaxel) Variant #01	ERBB2	R 78 254	21d	—	—	—	—	1
ddAC-THP (Paclitaxel) Variant #01	ERBB2	R 76 894	21d	—	—	—	—	1
AC-THP (Paclitaxel) Variant #01	ERBB2	R 76 870	21d	—	—	—	—	1
FAC-THP (Paclitaxel) Variant #01	ERBB2	R 76 843	21d	—	—	—	—	1
iddEnPC Variant #01	—	R 54 021	14d	—	—	—	—	—
AC-TH (Docetaxel) Variant #01	ERBB2	R 18 388	21d	—	—	—	—	2
FEC-TH (Docetaxel) Variant #01	ERBB2	R 17 412	21d	—	—	—	—	1
EC-TH (Docetaxel) Variant #02	ERBB2	R 17 343	21d	—	—	—	—	1
ddEC-TH (Docetaxel) Variant #01	ERBB2	R 17 343	21d	—	—	—	—	1
ddAC-TH (Docetaxel) Variant #01	ERBB2	R 15 960	21d	—	—	—	—	1
FAC-TH (Docetaxel) Variant #01	ERBB2	R 15 933	21d	—	—	—	—	1
ddFEC-ddTH (Docetaxel) Variant #01	ERBB2	R 15 893	21d	—	—	—	—	—
TH-FEC (Docetaxel) Variant #01	ERBB2	R 14 728	21d	—	—	—	—	—
EC-TH (Paclitaxel) Variant #01	ERBB2	R 14 180	21d	—	—	—	—	1
ddEC-TH (Paclitaxel) Variant #01	ERBB2	R 14 180	21d	—	—	—	—	1
ddAC-ddTH (Paclitaxel) Variant #01	ERBB2	R 13 933	14d	—	—	—	—	—
FEC-TH (Paclitaxel) Variant #01	ERBB2	R 13 922	21d	—	—	—	—	1
AC-TH (Paclitaxel) Variant #01	ERBB2	R 12 820	21d	—	—	—	—	3
ddAC-TH (Paclitaxel) Variant #01	ERBB2	R 12 796	21d	—	—	—	—	1
FAC-TH (Paclitaxel) Variant #01	ERBB2	R 12 769	21d	—	—	—	—	1
VH-FEC Variant #01	ERBB2	R 12 668	21d	—	—	—	—	—
TC-H (Docetaxel) Variant #01	ERBB2	R 12 650	21d	—	—	—	—	—
EC-H Variant #01	ERBB2	R 12 539	21d	—	—	—	—	—
T-H (Docetaxel) Variant #01	ERBB2	R 12 507	21d	—	—	—	—	—
FEC-H Variant #01	ERBB2	R 12 257	21d	—	—	—	—	—
T-H (Paclitaxel) Variant #01	ERBB2	R 10 992	21d	—	—	—	—	—
CMF-H Variant #01	ERBB2	R 10 828	21d	—	—	—	—	—
ECD-GC Variant #01	TNBC	R 7 749	21d	—	—	—	—	—
TX-CEX Variant #01	TNBC	R 5 793	21d	—	—	—	—	1
TX-CEX Variant #01	—	R 5 793	21d	—	—	—	—	1
iddEPC Variant #01	—	R 5 301	14d	—	—	—	—	1
AC-H Variant #01	ERBB2	R 5 191	21d	—	—	—	—	—
D-FEC Variant #01	—	R 5 123	21d	—	—	—	—	1
D-FEC Variant #01	TNBC	R 5 123	21d	—	—	—	—	1
D-FEC Variant #01	ERBB2	R 5 123	21d	—	—	—	—	1
FEC-D Variant #01	—	R 5 123	21d	—	29.0 mo	—	—	1
FEC-D Variant #01	TNBC	R 5 123	21d	—	29.0 mo	—	—	1
E-D Variant #01	—	R 4 935	28d	—	—	—	—	1
EC-D Variant #01	TNBC	R 4 860	21d	—	—	—	—	1
EC-D Variant #01	—	R 4 860	21d	—	—	—	—	1
TH-FEC (Docetaxel, SC Trastuzumab) Variant #01	ERBB2	R 4 616	21d	—	—	—	—	—
D-EC Variant #01	—	R 4 558	21d	—	—	—	—	—
ddEC-ddD Variant #01	—	R 4 171	14d	—	—	—	—	—
ddEC-T Variant #01	—	R 4 023	21d	—	—	—	—	1
ddFEC-ddD Variant #01	—	R 3 889	14d	—	—	—	—	—
AC-D Variant #01	ERBB2	R 3 477	21d	—	—	—	—	2
AC-D Variant #01	—	R 3 477	21d	—	—	—	—	2
T-FEC Variant #01	—	R 3 449	21d	—	—	—	—	—
EP-ddCMF Variant #01	—	R 3 421	21d	—	—	—	—	—
E-X Variant #01	—	R 3 409	21d	—	—	—	—	—
ddEC-ddT Variant #01	—	R 3 315	14d	—	—	—	—	2
EC-T Variant #01	—	R 3 315	21d	—	—	—	—	2
FEC-P Variant #01	—	R 2 877	21d	—	—	—	—	—
V-FEC Variant #01	ERBB2	R 2 746	21d	—	—	—	—	—
V-FEC Variant #01	—	R 2 746	21d	—	—	—	—	—
ddE-iddCMF Variant #01	—	R 2 711	14d	—	—	—	—	—
T-ddEC Variant #01	TNBC	R 2 656	14d	—	—	—	—	—
EC-CMF Variant #01	—	R 2 602	28d	—	—	—	—	—
E-CMF Variant #01	—	R 2 439	21d	—	—	—	—	3
AT-CMF Variant #01	—	R 2 415	28d	—	—	—	—	—
ddEC-ddCMF Variant #01	—	R 2 328	14d	—	75.9 mo	—	—	—
ddA-ddT-ddC Variant #01	—	R 1 931	14d	—	—	—	—	—
AC-T Variant #01	ERBB2	R 1 931	21d	—	—	—	—	2
ddAC-ddT Variant #01	—	R 1 931	14d	—	—	—	—	—
AC-T Variant #01	TNBC	R 1 931	21d	—	—	—	—	2
AC-T Variant #01	—	R 1 931	21d	—	—	—	—	2
CMF-E Variant #01	—	R 1 835	21d	—	—	—	—	—
FAC-T Variant #01	—	R 1 360	21d	—	—	—	—	—
T-ddAC Variant #01	TNBC	R 1 272	14d	—	—	—	—	—
ddAC-T Variant #01	—	R 1 272	14d	—	—	—	—	—
AC-CMF Variant #01	—	R 1 219	28d	—	—	—	—	—
A-CMF Variant #01	—	R 1 172	28d	—	—	—	—	—
FAC-MV Variant #01	—	R 503	28d	—	—	—	—	—

81 of 81 regimens shown